地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:18771149750
邮箱:sales@amyjet.com

艾美捷科技代理Rigaku Reagents品牌。
Rigaku Reagents 是 Rigaku 集团旗下的一家子公司,专注于为X射线晶体学领域提供高质量的化学试剂和工具。Rigaku 集团是全球知名的科学仪器制造商,尤其在X射线分析技术领域具有领先地位。Rigaku Reagents 的主要目标是支持科学家在蛋白质晶体学、材料科学和其他相关领域的研究,提供用于晶体生长、样品制备和分析的高质量试剂和耗材。热门产品包括:Wizard Classic/Wizard Cryo 系列蛋白结晶筛选试剂盒,结晶板,结晶工具,和 PEG3350、PEG6000、PEG8000 等试剂。主要产品类别为:
(1)晶体生长试剂:Rigaku Reagents 提供多种用于蛋白质和小分子晶体生长的试剂,包括结晶筛选试剂盒、缓冲液、沉淀剂和添加剂。这些试剂经过严格的质量控制,确保实验的可重复性和可靠性。
(2)结晶筛选试剂盒:公司提供多种结晶筛选试剂盒,如 Crystal Screen、Index Screen 和 SaltRx Screen,适用于不同类型的晶体生长实验。这些试剂盒设计科学,能够显著提高晶体生长的成功率。
(3)蛋白质结晶工具:提供用于蛋白质结晶的耗材和设备,如结晶板、密封膜和样品支架。这些工具与 Rigaku 的X射线衍射仪兼容,支持从晶体生长到数据分析的全流程。
(4)小分子结晶试剂:为小分子晶体学研究提供高质量的试剂和工具,支持药物开发、材料科学等领域的研究。
<<< " data-original="http://anogen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Rigaku Reagents品牌"> 艾美捷科技代理Rigaku Reagents品牌
<Welligton实验室始建于1980年,致力于为客户提供高品质的标准物质,并始终站在环境科学的前沿,Wellington以矢志不渝的信念不断地推出新的合成物质,用于检测环境中不断出现的污染物。
Wellington Laboratories has been committed to providing high quality reference standards and exceptional customer service since its inception in 1980. An acute awareness of trends in the environmental community and a dedication to research and development has allowed us to synthesize a variety of emerging contaminants over the years. A few examples of The Science Behind Wellington are provided below for your review.
Wellington Laboratories的主要产品包括:
PCDD/PCDF Analytical Method Solutions
Individual PCDDs & PCDFs: Native and Mass-Labelled
Specialty Solution/Mixtures of PCDDs and PCDFs
PCB Analytical Method Solutions
Individual PCBs: Mass-Labelled
Specialty Solution/Mixtures of PCBs
Halogenated Flame Retardants & Related Compounds
Perfluorinated Compounds (PFCs)
Certified Reference Materials
Additional Products
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://anogen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Wellington Laboratories"> Wellington Laboratories
GeneTex公司致力于研究和开发各种基础医学相关的新型研究用抗体。公司起初的核心目标是帮助科学家寻找引发人类乳腺癌的分子新靶标,现在已经逐步扩展到其他研究领域新抗体和配套诊断试剂的开发。至今,癌症研究相关抗体已经成为了该公司的特色产品。Genetex 公司以获得客户100%的满意度为目标,曾与多家著名抗体公司合作业务。目前抗体总数已逾50,000种,且每月推出近400种新抗体。
With a 20-year history of quality results, GeneTex sets itself apart from other antibody companies by taking the necessary steps to properly validate our antibodies. Antibody validation remains an industry-wide challenge with ramifications that can impact progress in the life sciences and medicine.
GeneTex的主要产品包括:
Primary Antibodies
Secondary Antibodies
Proteins & Peptides
Lysates & Slides
Serum & Reagents
Research Kits
Isotype Controls
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://anogen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="GeneTex"> GeneTex
DiaMetra公司位于意大利Perugia,致力于为诊断行业提供高品质产品,包括标品和检测试剂盒,涉及的检测领域包括:唾液试剂盒、高血压及钙的代谢、自体免疫疾病、糖尿病指标检测、肿瘤标志物、固醇类激素、性激素、甲状腺激素检测等。
Diametra is dedicated to providing quality products and the highest level of service in its target diagnostics segments. Through innovation and total commitment we strive to create value for our people, our customers and for the shareholders.
As an organization we constantly strive for innovation, not simply in the products we bring to the market but also in the way we interact with our customers and with each other. This is grounded in our solution driven approach to partnership.
产品主要应用领域:
Saliva kits
Hypertension / Calcium Metabolism
Controls
Autoimmune Diseases
Diabetes Monitoring
Tumor Markers
Steroids Hormones
Fertility Proteic Hormones
Thyroid Monitoring
Circulating Immuno Complexes
Miscellaneous
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理SCIEX 品牌。
SCIEX成立于1970年,由Dr. Barry French和多伦多大学航空航天系的其他科学家共同建立。SCIEX致力于通过科学的力量帮助应对复杂的科学挑战并改善世界,为全球科研工作者提供强有力的技术支持。SCIEX专注于研发和生产高性能的色谱分析仪器及相关技术和解决方案,特别是质谱和分离科学仪器。SCIEX的产品线包括多种色谱分析仪器、质谱系统以及相关的软件和服务。例如,其QTRAP®、TripleTOF®、Triple Quad™等质谱系统,以及Ekspert™ microLC 200超快速液相色谱等产品,被广泛应用于生命科学、临床研究、工业市场等多个领域。SCIEX的产品和技术在蛋白质生物标志物研究、疾病研究、药物研发、食品安全和环境检测等方面发挥着重要作用。SCIEX的产品和技术在全球范围内得到了广泛的应用和认可,为科研、临床和工业等领域提供了强有力的技术支持。
<<< " data-original="http://anogen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理SCIEX品牌"> 艾美捷科技代理SCIEX品牌
艾美捷科技特约代理Everest Biotech公司产品。
Everest Biotech公司成立于2000年,该公司主要生产山羊抗体,针对人类、小鼠、大鼠等物种的一系列重要的抗原。另外,Everest Biotech公司已通过ISO 9001:2015认证 (Certificate number CA14829),可靠的质量和个性化的服务,使得客户以遍布全球。
所有来自Everest Biotech的抗体均有以下特性
(1) Everest Biotech自主研发生产
(2)全部经过肽亲和纯化以保证最佳的特异性和纯度;
(3)经过免疫原肽的ELISA和WB实验验证;
(4)PhD科学家团队,提供全方位技术支持服务。
Everest Biotech - Experts in antigen affinity purified goat polyclonal antibodies.
Since 2000, Everest has been producing a catalog containing thousands of goat antibodies against a broad range of human, mouse and rat proteins of biomedical interest.
Everest Biotech's commitment to quality and continuous improvement has been recognised with ISO 9001:2015 accreditation (Certificate number CA14829). The customers can be assured they will receive high quality product and excellent customer service.
按疾病种类分:
Allergy
Autoimmunity
Cancer
Cardiovascular
Genetic Disorders
Infectious
Metabolic
Neuronal
按生物功能分:
Adhesion
Apoptosis and its regulation
Autophagy
Cell Cycle and DNA Repair
Chromatin, Histone and RNA regulation
CNS and PNS
Cytoskeletal elements
Embryogenesis and cell differentiation
GAP, GBP, GEF. GRP, GTPase proteins
Inflammation
lectins
Lipids and Sterols Pathways
Mitochondrial proteins
Protein integrity, maturation and break down
Protein Kinases
Protein Phosphatases and Inhibitors
Receptors
SH2 domain containing proteins
SH3 domain containing proteins
Transcriptional regulators
Transcription factors
Translation and its regulation
Transporters, protein sorting, channels
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://anogen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Everest Biotech"> Everest Biotech
艾美捷科技代理Steraloids Inc. 全系列产品。
Steraloids致力于为研究者提供2700种不同的类固醇雄激素,雌激素,孕激素,cholestins、胆汁酸、激素和代谢产物。
Steroids for Research: 2700 different androgens, estrogens, cholestins, progestins, bile-acids, hormones, and metabolites. Synthetic of endogenous, synthesized to purified standards.
<<| 产品列表 | ||
| 产品名称 | 产品编号 | CAS# |
| 1,(5α)-ANDROSTEN-4-AZA-3-ONE-17β-(N-TERT-BUTYL-CARBOXAMIDE) | A4370-000 | CAS 98319-26-7 |
| 1, (5α)-ANDROSTEN-3, 17-DIONE | A4400-000 | CAS 571-40-4 |
| 1(5α)-ANDROSTEN-1β-METHYL-17β-OL-3-ONE | A4420-000 | CAS 153-00-4 |
| 1(5α)-ANDROSTEN-1β-METHYL-17β-OL-3-ONE ACETATE | A4421-000 | CAS No |
| 1,(5α)-ANDROSTEN-1β-METHYL-17β-OL-3-ONE ENANTHATE | A4444-000 | CAS 303-42-4 |
| 1,(5α)-ANDROSTEN-2- METHYL-17β- OL-3-ONE | A4448-200 | CAS 5197-58-0 |
| 2(5α)-ANDROSTEN-17α-METHYL, 17β-OL | A4900-000 | CAS 3275-64-7 |
| 2, (5α)-ANDROSTEN-17β-OL | A4960-000 | CAS 2639-53-4 |
| 2, (5α)-ANDROSTEN-17β-OL ACETATE | A4961-000 | CAS No |
| 4-ANDROSTEN-3α, 17α-DIOL | A5480-000 | CAS 15183-38-7 |
| 4-ANDROSTEN-3α, 17α-DIOL DIACETATE | A5490-000 | CAS No |
| 4-ANDROSTEN-3α, 17β-DIOL | A5500-000 | CAS 1852-61-5 |
| 4-ANDROSTEN-4-OL-3, 17-DIONE METHYL ETHER | A6507-000 | CAS No |
| 4-ANDROSTEN-6α-OL-3, 17-DIONE | A6520-000 | CAS 24704-84-5 |
| 5-ANDROSTEN-17β-ACETAMIDO-3β-OL ACETATE | A7320-000 | CAS No |
| 5-ANDROSTEN-17β-AMINO-3β-OL | A7400-000 | CAS 4350-66-7 |
| 5-ANDROSTEN-16α-BROMO-3β-OL-17-ONE | A7500-000 | CAS No |
| 5α-ANDROSTAN-17α-METHYL-17β-OL-3-ONE | A2080-000 | CAS 521-11-9 |
| 5α-ANDROSTAN-17α-METHYL-17β-OL-3-ONE ACETATE | A2081-000 | CAS No |
| 5α-ANDROSTAN-17α-METHYL-17β-OL-3-ONE 3-0-CARBOXYMETHYLOXIME | A2085-000 | CAS No |
| 5α-ANDROSTAN-17α-METHYL-17β-OL-3-ONE HEMISUCCINATE | A2090-000 | CAS No |
| 5β-ANDROSTAN-17β-OL-3-ONE | A3730-000 | CAS 571-22-2 |
| 5β-ANDROSTAN-17β-OL-3-ONE ACETATE | A3731-000 | CAS No |
| 5β-ANDROSTAN-17β-OL-3-ONE BENZOATE | A3733-000 | CAS No |
| A-NOR-5α-ANDROSTAN-2α, 17α-DIETHYNYL-2β, 17β-DIOL DIPROPIONATE | N0100-000 | CAS 56470-64-5 |
| 9(11), (5α)-ANDROSTEN-3, 17-DIONE | A8950-000 | CAS 15375-19-6 |
| 9(11), (5β)-ANDROSTEN-3α-OL-17-ONE | A9000-000 | CAS 571-49-3 |
| 9(11),(5β)-ANDROSTEN-3β,17α-DIOL | A8940-000 | CAS No |
| 16, (5α)-ANDROSTEN-3-ONE-3-CMO | A9258-000 | CAS No |
| 16, (5α)-ANDROSTEN-3-ONE-3-CARBOXYMETHYLOXIME : BSA | A9260-000 | CAS No |
| 16, (5α)-ANDROSTEN-3-ONE-3-CMO : HORSERADISHPEROXIDASE | A9264-000 | CAS No |
| 5, 15,-ANDROSTADIEN-3β-0L-17-ONE | A0602-000 | CAS 17921-64-1 |
| 1, 4-ANDROSTADIENE-3, 17-DIONE | A0100-000 | CAS 897-06-3 |
| 1, 4-ANDROSTADIEN-3, 17-DIONE 17-ETHYLENEKETAL | A0110-000 | CAS 2398-63-2 |
| 3, 5-ANDROSTADIEN-17β-OL | A0353-000 | CAS 2602-86-0 |
| 3, 5-ANDROSTADIEN-3-OL-17-ONE 3-ETHYL ETHER | A0380-000 | CAS 972-46-3 |
| 4, 6-ANDROSTADIEN-17α-METHYL-17β-OL-3-ONE | A0402-000 | CAS No |
| 5, 16-ANDROSTADIEN-17-CYANO-3β-OL | A0630-000 | CAS No |
| 1, 4-ANDROSTADIEN-17β-OL-3-ONE GLUCURONIDE | A0207-200 | CAS No |
| 1, 4-ANDROSTADIEN-17α-METHYL-17β-OL-3-ONE | A0130-040 | CAS 72-63-9 |
| 1, 4-ANDROSTADIEN-17α-METHYL-6β, 17β-DIOL-3-ONE-6-ACETATE | A0125-080 | CAS No |
| 5, 16-ANDROSTADIEN-3β-OL-17β-CARBOXYLIC ACID 3-ACETATE | A0681-000 | CAS No |
| 5, 16-ANDROSTADIEN-3β-OL-17β-CARBOXYLIC ACID ETHYL ESTER | A0685-000 | CAS No |
| 5, 16-ANDROSTADIEN-3β-OL-17β-CARBOXYLIC ACID METHYL ESTER | A0689-000 | CAS No |
| 5, 16-ANDROSTADIEN-3-ONE-17β-CARBOXYLIC ACID | A0695-000 | CAS No |
| 1, 4-ANDROSTADIEN-17α-OL-3-ONE | A0190-000 | CAS No |
| 1, 4-ANDROSTADIEN-6β,17β-DIOL-3-ONE | A0085-000 | CAS No |
| 4, 16-ANDROSTADIEN-3α-OL | A0555-000 | CAS 6306-63-0 |
| 1, 4-ANDROSTADIEN-17β-OL-3-ONE-2,4,6,6-d4 | A0200-040 | CAS 846-48-0 |
| 1, 4, 6-ANDROSTATRIEN-17β-OL-3-ONE ACETATE | A4201-000 | CAS No |
| 1, 4, 7-ANDROSTATRIEN-17β-OL-3-ONE | A4250-000 | CAS No |
| 4-CHOLESTEN-3β-OL ACETATE | C6101-000 | CAS No |
| 4-CHOLESTEN-3β-OL BENZOATE | C6103-000 | CAS No |
| 4-CHOLESTEN-2α-OL-3-ONE | C6180-000 | CAS No |
| 5-CHOLESTEN-3β, 25-DIOL 3-HEMISUCCINATE | C6520-000 | CAS No |
| 5-CHOLESTEN-3β, 25-DIOL 3-OLEATE | C6525-000 | CAS No |
| 5-CHOLESTEN-3, 25-DIOL, 25-SULPHATE, SODIUM SALT | C6538-000 | CAS No |
| 5-CHOLESTEN-3β, 25-DIOL-7-ONE | C6550-000 | CAS No |
| 5-CHOLESTEN-3β, 25-DIOL-7-ONE ACETATE | C6551-000 | CAS No |
| 5-, 25R-CHOLESTEN-3β, 26-DIOL | C6570-000 | CAS 20380-11-4 |
| 5-CHOLESTEN-24(S), 25-EPOXY-3β-OL | C6640-000 | CAS 77058-74-3 |
| 5-CHOLESTEN-24β-ETHYL-3β-OL ~78% | C6680-000 | CAS 83-46-5 |
| 5-CHOLESTEN-24β-ETHYL-3β-OL -25,26,26,26,27,27,27 -D7 | C6680-015 | CAS 83-46-5 |
| 5-CHOLESTEN-24β-ETHYL-3β-OL ~54% | C6680-050 | CAS 83-46-5 |
| 5-CHOLESTEN-24β-ETHYL-3β-OL ~78% | C6680-080 | CAS 000083-46-5 |
| 5-CHOLESTEN-24β-ETHYL-3β-OL ACETATE | C6681-000 | CAS 000915-05-9 |
| 5-CHOLESTEN-24α-ETHYL-3β-OL CHLOROFORMATE | C6683-000 | CAS No |
| 5-CHOLESTEN-24-ETHYL-3-OL-7-ONE | C6684-000 | CAS 2034-74-4 |
| 5-CHOLESTEN-24(28)-ETHYLIDENE-3β-OL | C6685-000 | CAS 17605-67-3 |
| 5-CHOLESTEN-25-FLUORO-3βOL | C6688-000 | CAS No |
| 5-CHOLESTEN-24α-METHYL 3β-OL | C6700-000 | CAS 474-62-4 |
| 5-CHOLESTEN-24α-METHYL 3β-OL-30% 24β | C6700-010 | CAS 474-62-4 |
| 5-CHOLESTEN-24α-METHYL 3β-OL-BENZOATE | C6703-000 | CAS No |
| 5-CHOLESTEN-6-NITRO-3β-OL ACETATE | C6711-000 | CAS No |
| 5-CHOLESTEN-6-NITRO-3β-OL BENZOATE | C6713-000 | CAS No |
| 5-CHOLESTEN-3α-OL | C6730-000 | CAS No |
| 5-CHOLESTEN-3α-OL ACETATE | C6731-000 | CAS No |
| 5-CHOLESTEN-3β-OL | C6760-000 | CAS 57-88-5 |
| 5-CHOLESTEN-3β-OL-25,26,26,26,27,27,27-D7 | C6760-020 | CAS 57-88-5 |
| 5-CHOLESTEN-3β-OL ACETATE | C6761-000 | CAS 604-35-3 |
| 5-CHOLESTEN-3β-OL ACETOACETATE | C6762-000 | CAS No |
| 5-CHOLESTEN-3β-OL N-BUTYRATE | C6775-000 | CAS 521-13-1 |
| 5-CHOLESTEN-3β-OL BENZOATE | C6770-000 | CAS 604-32-0 |
| 5-CHOLESTEN-3-OL CAPROATE | C6780-000 | CAS No |
| 5-CHOLESTEN-3β-OL CAPRYLATE | C6785-000 | CAS No |
| 5-CHOLESTEN-3β-OL-(25R)CARBOXYLIC ACID | C6786-000 | CAS No |
| 5-CHOLESTEN-3β-OL-(25S)CARBOXYLIC ACID | C6787-000 | CAS No |
| 5-CHOLESTEN-3β-OL CHLOROACETATE | C6790-000 | CAS 3464-50-4 |
| 5-CHOLESTEN-3β-OL CHLOROFORMATE | C6795-000 | CAS 7144-08-3 |
| 5-CHOLESTEN-3β-OL CINNAMATE | C6800-000 | CAS 1990-11-0 |
| 5-CHOLESTEN-3β-OL N-DECYLATE | C6805-000 | CAS 1183-04-6 |
| 5-CHOLESTEN-3-OL DOCOSAHEXAENOATE(4,7,10,13,16,19) | C6807-000 | CAS No |
| 5-CHOLESTEN-3β-OL ETHYL ETHER | C6812-000 | CAS 98-61-96 |
| 5-CHOLESTEN-3β-OL FORMATE | C6815-000 | CAS 4351-55-7 |
| 5-CHOLESTEN-3β-OL GLUCOSIDURONATE, SODIUM SALT | C6821-000 | CAS No |
| 5-CHOLESTEN-3β-OL HEMISUCCINATE | C6823-000 | CAS 1510-21-0 |
| 5-CHOLESTEN-3β-OL N-HEPTYLATE | C6825-000 | CAS 1182-07-6 |
| 5-CHOLESTEN-3β-OL ISO-BUTYRATE | C6840-000 | CASNoCH Groups C31 H52 |
| 5-CHOLESTEN-3β-OL LAURATE | C6845-000 | CAS 190-8-11-8 |
| 5-CHOLESTEN-3β-OL METHYLCARBONATE | C6855-000 | CAS 15507-52-5 |
| 5-CHOLESTEN-3β-OL METHYL ETHER | C6860-000 | CAS 1174-92-1 |
| 5-CHOLESTEN-3β-OL MYRISTATE | C6865-000 | CAS 1989-52-2 |
| 5-CHOLESTEN-3β-OL OLEATE | C6870-000 | CAS 303-43-5 |
| 5-CHOLESTEN-3β-OL OLEYL ETHER | C6871-000 | CAS No |
| 5-CHOLESTEN-3β-OL PALMITATE | C6875-000 | CAS No |
| 5-CHOLESTEN-3β-OL PELARGONATE | C6880-000 | CAS 1182-66-7 |
| 5-CHOLESTEN-3-OL PHENYLPROPIONATE | C6890-000 | CAS 14914-99-9 |
| 5-CHOLESTEN-3β-OL PROPIONATE | C6895-000 | CAS 633-31-8 |
| 5-CHOLESTEN-3β-OL PYRIDINIUM SULPHATE | C6903-000 | CAS No |
| 5-CHOLESTEN-3β-OL STEARATE | C6904-000 | CAS 35602-69-8 |
| 5-CHOLESTEN-3β-OL SULPHATE, SODIUM SALT | C6905-000 | CAS 2864-50-8 |
| 5-CHOLESTEN-3β-OL P-TOLUENESULPHONATE | C6910-000 | CAS 1182-65-6 |
| 5-CHOLESTEN-3β-OL SULPHATE TRIETHYL AMMONIUM SALT | C6911-000 | CAS No |
| 5-CHOLESTEN-3β-OL N-VALERATE | C6915-000 | CAS 1182-07-6 |
| 5-CHOLESTEN-3β-OL-7-ONE | C6970-000 | CAS 566-28-9 |
| 5-CHOLESTEN-3β-OL-7-ONE ACETATE | C6971-000 | CAS No |
| 5-CHOLESTEN-3β-OL-7-ONE BENZOATE | C6973-000 | CAS No |
| 5-CHOLESTEN-3-OL-7-ONE-7-CARBOXYMETHYLOXIME | C6980-000 | CAS 566-28-9 |
| 5-CHOLESTEN-3-OL-22-ONE | C7020-000 | CAS 19243-30-2 |
| 5-CHOLESTEN-3-OL-22-ONE ACETATE | C7021-000 | CAS No |
| 5-CHOLESTEN-3β- OL-24-ONE | C7030-000 | CAS 17752-16-8 |
| 5-CHOLESTEN-3-ONE | C7050-000 | CAS 601-54-7 |
| 5-CHOLESTEN-7-ONE | C7060-000 | CAS No |
| 5-CHOLESTEN-3, 7α, 25-TRIOL | C7085-000 | CAS No |
| 5-CHOLESTEN-3β, 16β, 26(25R)-TRIOL | C7090-000 | CAS No |
| 5-CHOLESTEN-3, 17α, 20α-TRIOL | C7100-000 | CAS No |
| N-ACETYL-5-METHOXYTRYPTAMINE-α,α,β,β-D4 | Z0600-000 | CAS 73-31-4 |
| 5-CHOLESTEN-3β, 4α-DIOL | C6400-000 | CAS 34310-86-6 |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://anogen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Steraloids"> Steraloids
Anogen-Yes Biotech Laboratories Ltd. 创建于1989年, 位于加拿大多伦多近郊的著名高科技城市密西沙加市。Anogen是加拿大逸士生物技术研究有限公司在国际上的市场经销部门。Anogen-Yes Biotech Laboratories Ltd.研发和生产各种新颖抗体及有关产品,应用广泛的技术平台设计和开发各种单克隆抗体、多克隆抗体、基因工程/人源化抗体、免疫检验用配对抗体、免疫球蛋白、活性多肽、酶联免疫试剂盒[ELISA]、斑点酶联免疫试剂盒[Elispots]和基因重组蛋白质等等。 这些产品主要用于生命科学研究和各种疾病的诊断和防治,包括炎症和自身免疫性疾病、心血管病和癌症等。
Anogen is the trade name of Yes Biotech Laboratories Ltd., a Canadian biopharmaceutical company based in Mississauga, Ontario. Founded in 1989, Anogen-Yes Biotech specializes in developing and manufacturing monoclonal antibodies, recombinant proteins, synthetic bioactive peptides, and Enzyme linked immunosorbent assay (ELISA) kits for research as well as diagnostic and therapeutic use.[1] It is also committed to seeking medical treatment of cancer, autoimmune, inflammatory and cardiovascular diseases by developing antibody-based biopharmaceuticals.
Anogen的主要产品包括:
Monoclonal Antibodies
Polyclonal Antibodies
Matched Antibody Pairs
ELISA Kits
按照研究领域细分:
Inflammatory & Growth Factors
Cell Biology & Molecular Biology
Immunoassay Reagents
Infection & Toxin
Coagulation Factors
Hormone
Neurological Disorder
Tumor Research
| 品名 | 货号 | 规格 |
| mAb anti-Human TNF-α, CH8810 | MO-C40003A | 0.1 mg |
| mAb anti-Human TNF-α, CH8820, Capture | MO-C40003B | 0.1 mg |
| mAb anti-Human TNF-α, C2H9 | MO-C40003D | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Detector | MO-C40003E | 0.1 mg |
| mAb anti-Human TNF-α, C2A7 | MO-C40003F | 0.1 mg |
| mAb anti-Human TNF-α, C5G7 | MO-C40003G | 0.1 mg |
| mAb anti-Human TNF-α, C4C7 | MO-C40003H | 0.1 mg |
| mAb anti-Human IFN-γ, 315 | MO-C40004D | 0.1 mg |
| mAb anti-Human IFN-γ, 165 | MO-C40004E | 0.1 mg |
| mAb anti-Human IFN-γ, 23 | MO-C40004F | 0.1 mg |
| mAb anti-Human CCR1, 293 | MO-C40005A | 0.1 mg |
| mAb anti-Human TGF-β, TB21 | MO-C40009A | 0.1 mg |
| mAb anti-Human TGF-β, 2C5 | MO-C40009B | 0.1 mg |
| mAb anti-Human TGF-β, 2C6 | MO-C40009D | 0.1 mg |
| mAb anti-Human TGF-β, 2E6 | MO-C40009E | 0.1 mg |
| mAb anti-Human TGF-β, 8C4 | MO-C40009F | 0.1 mg |
| mAb anti-Human IL-8, I8-S2, Capture | MO-C40017A | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Detector | MO-C40017D | 0.1 mg |
| mAb anti-Human IL-8, I8-61 | MO-C40017E | 0.1 mg |
| mAb anti-Human IL-8, 257 | MO-C40017F | 0.1 mg |
| mAb anti-Human IL-8, 807 | MO-C40017G | 0.1 mg |
| mAb anti-Human MCP-1, S8 | MO-C40021A | 0.1 mg |
| mAb anti-Human MCP-1, S14, Capture | MO-C40021B | 0.1 mg |
| mAb anti-Human MCP-1, S101, Detector | MO-C40021D | 0.1 mg |
| mAb anti-Human MCP-1, 9G10 | MO-C40021E | 0.1 mg |
| mAb anti-Human MCP-1, S382 | MO-C40021F | 0.1 mg |
| mAb anti-Human SAA, 115, Capture | MO-C40028A | 0.1 mg |
| mAb anti-Human SAA, 513 | MO-C40028D | 0.1 mg |
| mAb anti-Human SAA, 607, Detector | MO-C40028E | 0.1 mg |
| mAb anti-Human SAA, 291 | MO-C40028G | 0.1 mg |
| mAb anti-Human SAA, 504 | MO-C40028H | 0.1 mg |
| mAb anti-Human SAA, 585 | MO-C40028J | 0.1 mg |
| mAb anti-Human SAA, 426 | MO-C40028K | 0.1 mg |
| mAb anti-Human SAA, 38 | MO-C40028L | 0.1 mg |
| mAb anti-Human SAA, 132 | MO-C40028M | 0.1 mg |
| mAb anti-Human SAA, S3 | MO-C40028N | 0.1 mg |
| mAb anti-Human IL-1β, S1H12 | MO-C40029A | 0.1 mg |
| mAb anti-Human IL-1β, S1B7 | MO-C40029B | 0.1 mg |
| mAb anti-Human IL-1β, S3F12 | MO-C40029G | 0.1 mg |
| mAb anti-Human IL-1β, 464 | MO-C40029H | 0.1 mg |
| mAb anti-Human IL-2, 5A8, | MO-C40032A | 0.1 mg |
| mAb anti-Human IL-2, 9F9, | MO-C40032B | 0.1 mg |
| mAb anti-Human IL-2, 10C4 | MO-C40032C | 0.1 mg |
| mAb anti-Human IL-2, 8C2 | MO-C40032D | 0.1 mg |
| mAb anti-Human IL-2, 6F11 | MO-C40032E | 0.1 mg |
| mAb anti-Human IL-2, 6B1 | MO-C40032F | 0.1 mg |
| mAb anti-Human EGF, S-21 | MO-C40044A | 0.1 mg |
| mAb anti-Human EGF, S-120 | MO-C40044B | 0.1 mg |
| mAb anti-Human EGF, S-134, Capture | MO-C40044D | 0.1 mg |
| mAb anti-Human EGF, S-145 | MO-C40044E | 0.1 mg |
| mAb anti-Human EGF, S-146, Detector | MO-C40044F | 0.1 mg |
| mAb anti-Human EGF, S-147 | MO-C40044G | 0.1 mg |
| mAb anti-Human EGF, S-177 | MO-C40044H | 0.1 mg |
| mAb anti-Human G-CSFR, S-1252 | MO-C40045A | 0.1 mg |
| mAb anti-Human G-CSFR, S-1268 | MO-C40045B | 0.1 mg |
| mAb anti-Human G-CSFR, S-1284 | MO-C40045D | 0.1 mg |
| mAb anti-Human G-CSFR, S-1374 | MO-C40045E | 0.1 mg |
| mAb anti-Human G-CSFR, S-425 | MO-C40045F | 0.1 mg |
| mAb anti-Human G-CSFR, S-1390 | MO-C40045G | 0.1 mg |
| mAb anti-Human bFGF, F-343 | MO-C40046A | 0.1 mg |
| mAb anti-Human bFGF, F-74 | MO-C40046B | 0.1 mg |
| mAb anti-Human bFGF, F-474 | MO-C40046F | 0.1 mg |
| mAb anti-Human bFGF, F-3 | MO-C40046H | 0.1 mg |
| mAb anti-Human EPO, 85 | MO-C40047A | 0.1 mg |
| mAb anti-Human M-CSF, 116 | MO-C40048A | 0.1 mg |
| mAb anti-Human M-CSF, 692 | MO-C40048B | 0.1 mg |
| mAb anti-Human M-CSF, 21 | MO-C40048D | 0.1 mg |
| mAb anti-Human MIP-1α, 116 | MO-C40051A | 0.1 mg |
| mAb anti-Human MIP-1α, 125 | MO-C40051D | 0.1 mg |
| mAb anti-Human MIP-1α, 548 | MO-C40051F | 0.1 mg |
| mAb anti-Human MIP-1α, 199 | MO-C40051G | 0.1 mg |
| mAb anti-Human MIP-1α, 400 | MO-C40051L | 0.1 mg |
| mAb anti-Human MIP-1α, 103 | MO-C40051M | 0.1 mg |
| mAb anti-Human MIP-1α, 376 | MO-C40051N | 0.1 mg |
| mAb anti-Human MIP-1α, 426 | MO-C40051P | 0.1 mg |
| mAb anti-Human MCP-3, 113, Detector | MO-C40088A | 0.1 mg |
| mAb anti-Human MCP-3, 343 | MO-C40088B | 0.1 mg |
| mAb anti-Human MCP-3, 490 | MO-C40088D | 0.1 mg |
| mAb anti-Human MCP-3, 768 | MO-C40088E | 0.1 mg |
| mAb anti-Human MCP-3, 1057 | MO-C40088F | 0.1 mg |
| mAb anti-Human MCP-3, 542, Capture | MO-C40088G | 0.1 mg |
| mAb anti-Human MCP-3, 1015 | MO-C40088H | 0.1 mg |
| mAb anti-Human IL-16, 59 | MO-C40089G | 0.1 mg |
| mAb anti-Human IL-16, 210 | MO-C40089H | 0.1 mg |
| mAb anti-Human IL-16, 323, Detector | MO-C40089J | 0.1 mg |
| mAb anti-Human IL-16, 398, Capture | MO-C40089K | 0.1 mg |
| mAb anti-Human IL-16, 568 | MO-C40089M | 0.1 mg |
| mAb anti-Human IL-16, 572 | MO-C40089N | 0.1 mg |
| mAb anti-Human GM-CSF, 29 | MO-C40090A | 0.1 mg |
| mAb anti-Human GM-CSF, 59, Capture | MO-C40090B | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Detector | MO-C40090D | 0.1 mg |
| mAb anti-Human GM-CSF, 204 | MO-C40090E | 0.1 mg |
| mAb anti-Human GM-CSF, 489 | MO-C40090F | 0.1 mg |
| mAb anti-Human GM-CSF, 120 | MO-C40090G | 0.1 mg |
| mAb anti-Human GM-CSF, 26 | MO-C40090H | 0.1 mg |
| mAb anti-Human GM-CSF, 174 | MO-C40090K | 0.1 mg |
| mAb anti-Human GM-CSF, S333 | MO-C40090L | 0.1 mg |
| mAb anti-Human IL-6, 2E10 | MO-C40091B | 0.1 mg |
| mAb anti-Human IL-6, 8E10 | MO-C40091C | 0.1 mg |
| mAb anti-Human IL-6, 5G8 | MO-C40091D | 0.1 mg |
| mAb anti-Human IL-6, 1B6 | MO-C40091E | 0.1 mg |
| mAb anti-Human IL-6, 1E3 | MO-C40091F | 0.1 mg |
| mAb anti-Human IL-6, 6D7 | MO-C40091G | 0.1 mg |
| mAb anti-Human IL-6, 9D8 | MO-C40091H | 0.1 mg |
| mAb anti-Human IL-10, 4H2 | MO-C40092A | 0.1 mg |
| mAb anti-Human IL-10, 6D2 | MO-C40092B | 0.1 mg |
| mAb anti Human IL-17A clone 4C1, Capture | MO-C40093A | 0.1mg |
| mAb anti Human IL-17A clone 2F3 | MO-C40093B | 0.1mg |
| mAb anti Human IL-17A clone 8H7 | MO-C40093C | 0.1mg |
| mAb anti Human IL-17A clone 5B4 | MO-C40093D | 0.1mg |
| mAb anti Human IL-17A clone 1E2 | MO-C40093E | 0.1mg |
| mAb anti Human IL-17A clone 2D11 | MO-C40093H | 0.1mg |
| mAb anti Human IL-17A clone 3C1 | MO-C40093I | 0.1mg |
| mAb anti Human IL-17A clone 3H11, Detector | MO-C40093K | 0.1mg |
| mAb anti Human IL-17A clone 5A9 | MO-C40093M | 0.1mg |
| mAb anti Human IL-17A clone 6F12 | MO-C40093O | 0.1mg |
| mAb anti Human IL-17A clone 7F10 | MO-C40093S | 0.1mg |
| mAb anti Human IL-17A clone 10F9 | MO-C40093W | 0.1mg |
| mAb anti Human IL-18 clone 2A10, Capture | MO-C40094A | 0.1mg |
| mAb anti Human IL-18 clone 10H4, Detector | MO-C40094B | 0.1mg |
| mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled) | MO-C40094TB | 0.1 mL |
| mAb anti Human IL-15 clone 5E8, Capture | MO-C40095A | 0.1mg |
| mAb anti Human IL-15 clone B1H6, Detector | MO-C40095B | 0.1mg |
| mAb anti-human LIF, Clone 2C6 | MO-C40096A | 0.1mg |
| mAb anti-human LIF, Clone 3F4 | MO-C40096B | 0.1mg |
| mAb anti-human LIF, Clone 8B10 | MO-C40096C | 0.1mg |
| mAb anti-DYKDDDDK (Flag) Tag, Flag.10F4 | MO-H40001B | 0.1 mg |
| mAb anti-GAPDH, H8 | MO-H40002A | 0.1 mg |
| mAb anti-HA Tag, HA52 | MO-H40004A | 0.1 mg |
| mAb anti-His Tag, 10A12 | MO-H40005B | 0.1 mg |
| mAb anti-Myc Tag, MycA7 | MO-H40006A | 0.1 mg |
| mAb anti-V5 Tag, V531 | MO-H40007A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 473, Detector | MO-I40002A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 163 | MO-I40002C | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 340, Capture | MO-I40002D2 | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 587, 0.1 mg | MO-I40002E | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 425 | MO-I40002I | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 1027 | MO-I40002J | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 287 | MO-I40002N | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 161 | MO-I40002P | 0.1 mg |
| mAb anti-HBsAg, RM-1 | MO-I40013A | 0.1 mg |
| mAb anti-HCV Core Protein, A1/3D1 | MO-I40015A | 0.1 mg |
| mAb anti-HCV Core Protein, B2 | MO-I40015B | 0.1 mg |
| mAb anti-HCV Core Protein, C3 | MO-I40015E | 0.1 mg |
| mAb anti-HCV NS-4, 7B7/5G9 | MO-I40016B | 0.1 mg |
| mAb anti-HCV NS-4, 5D4/10E7 | MO-I40016D | 0.1 mg |
| mAb anti-HCV NS-4, 7E11 | MO-I40016F | 0.1 mg |
| mAb anti-HCV NS-4, 202 | MO-I40016J | 0.1 mg |
| mAb anti-HCV NS-4, 101 | MO-I40016K | 0.1 mg |
| mAb anti-HCV NS-4, 174 | MO-I40016L | 0.1 mg |
| mAb anti-HCV NS-4, 497 | MO-I40016M | 0.1 mg |
| mAb anti-HCV NS-3, 70-13 | MO-I40018A | 0.1 mg |
| mAb anti-HCV NS-3, 1-5 | MO-I40018B | 0.1 mg |
| mAb anti-HCV NS-3, 12-15 | MO-I40018D | 0.1 mg |
| mAb anti-HCV NS-3, 5-11 | MO-I40018E | 0.1 mg |
| mAb anti-HCV NS-3, 24-8 | MO-I40018F | 0.1 mg |
| mAb anti-HCV NS-3, 20-8 | MO-I40018G | 0.1 mg |
| mAb anti-HCV NS-3, 113 | MO-I40018H | 0.1 mg |
| mAb anti-HCV NS-3, 281 | MO-I40018J | 0.1 mg |
| mAb anti-HCV NS-3, 806 | MO-I40018K | 0.1 mg |
| mAb anti-HCV NS-3, 5 | MO-I40018L | 0.1 mg |
| mAb anti-HCV NS-3, 328 | MO-I40018M | 0.1 mg |
| mAb anti-HCV NS-3, 251 | MO-I40018N | 0.1 mg |
| mAb anti-HCV NS-3, 242 | MO-I40018P | 0.1 mg |
| mAb anti-HCV NS-3, 133 | MO-I40018Q | 0.1 mg |
| mAb anti-HEV, S-13 | MO-I40019B | 0.1 mg |
| mAb anti-HEV, 4H5 | MO-I40019C | 0.1 mg |
| mAb anti-HEV, 2H6 | MO-I40019D | 0.1 mg |
| mAb anti-HEV, 2H2 | MO-I40019E | 0.1 mg |
| mAb anti-HEV, 1B6 | MO-I40019F | 0.1 mg |
| mAb anti-HEV, 5H4 | MO-I40019G | 0.1 mg |
| mAb anti-HP CagA, 10E9, | MO-I40020A | 0.1 mg |
| mAb anti-HP CagA, 5H10 | MO-I40020B | 0.1 mg |
| mAb anti-HP CagA, 5C6 | MO-I40020C | 0.1 mg |
| mAb anti-HP CagA, 3C10, | MO-I40020D | 0.1 mg |
| mAb anti-HP CagA, 3C1 | MO-I40020E | 0.1 mg |
| mAb anti-TB 38KD Antigen, D2G2 | MO-I40021A | 0.1 mg |
| mAb anti-TB 38KD Antigen, C12H11 | MO-I40021B | 0.1 mg |
| mAb anti-TB 38KD Antigen, C11B10 | MO-I40021C | 0.1 mg |
| mAb anti-TB 38KD Antigen, B12F8 | MO-I40021D | 0.1 mg |
| mAb anti-TB 38KD Antigen, A11D2 | MO-I40021E | 0.1 mg |
| mAb anti-TB 38KD Antigen, A2H8 | MO-I40021F | 0.1 mg |
| mAb anti-Human CD3, JXT3 | MO-L40001A | 0.1 mg |
| Rat anti-Mouse CD4, JXYT4 | MO-L40026 | 0.1 mg |
| Rat anti-Mouse CD8, JXYT8 | MO-L40027 | 0.1 mg |
| mAb anti-Human CD11α, A11 | MO-L40028 | 0.1 mg |
| mAb anti-Human HLA-ABC, LY5.1 | MO-L40033 | 0.1 mg |
| mAb anti-Human CD71 Transferrin Receptor, CY-TFR | MO-L40042 | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 1C4 | MO-L40043A | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 7C9, Capture | MO-L40043B | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 9E11 | MO-L40043E | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 9B4 | MO-L40043F | 0.1 mg |
| mAb anti-Human PD-1 / CD279, B1C4 | MO-L40043G | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 7G12, Detector | MO-L40043L | 0.1 mg |
| mAb anti-Human PD-1 / CD279, 2H7 | MO-L40043M | 0.1 mg |
| mAb anti Human PD-L1, clone 6A5 | MO-L40044E | 0.1 mg |
| mAb anti Human PD-L1 clone 8C12 | MO-L40044F | 0.1 mg |
| mAb anti Human PD-L1 clone 12B4, Detector | MO-L40044I | 0.1 mg |
| mAb anti Human PD-L1 clone 11D11 | MO-L40044M | 0.1 mg |
| mAb anti Human PD-L1 clone 15G3, Capture | MO-L40044N | 0.1 mg |
| mAb anti Human PD-L1 clone 12D9 | MO-L40044O | 0.1 mg |
| mAb anti Human PD-L1 clone 15F2 | MO-L40044R | 0.1 mg |
| mAb anti Human PD-L1, clone 10B12 | MO-L40044S | 0.1 mg |
| mAb anti Human CD47, clone 1G10 | MO-L40045A | 0.1 mg |
| mAb anti Human CD47, clone 8H7 | MO-L40045B | 0.1 mg |
| mAb anti Human CD47, clone 9F10 | MO-L40045C | 0.1 mg |
| mAb anti Human CD44, clone 2G7 | MO-L40046A | 0.1 mg |
| mAb anti Human CD44, clone 3C7 | MO-L40046B | 0.1 mg |
| mAb anti-hCG-α, CH5 | MO-M40010A | 0.1 mg |
| mAb anti-hCG-α, CH7 | MO-M40010B | 0.1 mg |
| mAb anti-TRICHOSANTHIN (TCST), TCST-1, 0.1 mg | MO-M40011A | 0.1 mg |
| mAb anti-hGH, YC6, Capture | MO-M40012A | 0.1 mg |
| mAb anti-Human Ig Kappa Light Chain, YCK1 | MO-M40020 | 0.1 mg |
| mAb anti-Human B2MG, D6E4 | MO-M40021B | 0.1 mg |
| mAb anti-Human B2MG, D2E9, Capture | MO-M40021C | 0.1 mg |
| mAb anti-Human B2MG, D6D1 | MO-M40021D | 0.1 mg |
| mAb anti-Human B2MG, D2A10 | MO-M40021E | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Detector | MO-M40021F | 0.1 mg |
| mAb anti-human CRP, 63F4, Capture | MO-M40023A | 0.1 mg |
| mAb anti-human CRP, 67A1 | MO-M40023B | 0.1 mg |
| mAb anti-human CRP, N1G1 | MO-M40023D | 0.1 mg |
| mAb anti-human CRP, S5G1 | MO-M40023E | 0.1 mg |
| mAb Rat anti-Aflatoxin, 1C6, 0.1 mg | MO-M40025A | 0.1 mg |
| mAb Rat anti-Aflatoxin, 1E6, 0.1 mg | MO-M40025B | 0.1 mg |
| mAb Rat anti-Aflatoxin, 2E4 | MO-M40025D | 0.1 mg |
| mAb anti-Human Albumin, S4D6 | MO-M40036 | 0.1 mg |
| mAb anti-Human Factor IX, F9-1, .01 mg | MO-M40037 | 0.1 mg |
| mAb anti-Human Protein C, HLW-C, 0.1 mg | MO-M40038 | 0.1 mg |
| mAb anti-Human Factor X, F10-1, 0.1 mg | MO-M40039 | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 237, 0.1 mg | MO-M40040A | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 474, 0.1 mg | MO-M40040B | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, Y8 | MO-M40040D | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 700 | MO-M40040E | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 585 | MO-M40040F | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 8 | MO-M40040H | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 291 | MO-M40040J | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 262 | MO-M40040N | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 71 | MO-M40040Q | 0.1 mg |
| mAb anti-Human GP IIb/IIIa, 128 | MO-M40040S | 0.1 mg |
| mAb anti-Staphylococcal Enterotoxin B [SEB], 0.1 mg | MO-M40041 | 0.1 mg |
| mAb anti-Human PTP1-C, PTY6 | MO-M40043A | 0.1 mg |
| mAb anti-Human PTP1-C, PTY11 | MO-M40043B | 0.1 mg |
| mAb anti-Human PTP1-C, PTY15 | MO-M40043D | 0.1 mg |
| mAb anti-Human PTP1-C, PTY10 | MO-M40043E | 0.1 mg |
| mAb anti-Human PTP1-C, PTY13 | MO-M40043F | 0.1 mg |
| mAb anti-human TSH, TSH-2, Detector | MO-M40046A | 0.1 mg |
| mAb anti-human TSH, TSH-1, Capture | MO-M40046B | 0.1 mg |
| mAb anti-Human Prolactin, PRL-1, Capture | MO-M40047B | 0.5 mg |
| mAb anti-Human LH, LH-1, Capture | MO-M40048B | 0.5 mg |
| mAb anti-hCG, HCG-1, Capture | MO-M40049B | 0.5 mg |
| mAb anti-Human FSH, FSH-1, Capture | MO-M40050B | 0.5 mg |
| mAb anti-Human Raf-1, 410 | MO-M40091E | 0.5 mg |
| mAb anti-Human Raf-1, 540 | MO-M40091G | 0.5 mg |
| mAb anti-Human Raf-1, 863 | MO-M40091J | 0.5 mg |
| mAb anti-Human Raf-1, 163 | MO-M40091M | 0.5 mg |
| mAb anti-Human NSE, 145 | MO-M40092A | 0.5 mg |
| mAb anti-Human NSE, 1G6 | MO-M40092B | 0.5 mg |
| mAb anti-Human NSE, 171 | MO-M40092C | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 3B3 | MO-M40093A | 0.1 mg |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Detector | MO-M40093B | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 3F8 | MO-M40093D | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 3F5 | MO-M40094A | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 1H3 | MO-M40094B | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 6C8 | MO-M40094C | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 5B8, Capture | MO-M40094D | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 4A2 | MO-M40094E | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 7H7 | MO-M40094F | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 5A4 | MO-M40094G | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 4B7 | MO-M40094H | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 7G10 | MO-M40094I | 0.5 mg |
| mAb anti-Amyloid β Peptide N-terminal, NT 1F10 | MO-M40094J | 0.5 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Detector | MO-M40095A | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, CV9 8B2 | MO-M40095B | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, 4B1 | MO-M40095C | 0.1 mg |
| mAb anti-Human α1-antitrypsin, 5G5 | MO-M40096A | 0.1 mg |
| mAb anti-Human α1-antitrypsin, 9F2 | MO-M40096B | 0.1 mg |
| mAb anti-Human α-Synuclein, 4H11 | MO-M40097A | 0.1 mg |
| mAb anti-Human α-Synuclein, 4C1 | MO-M40097B | 0.1 mg |
| mAb anti-Human α-Synuclein, 4B4 | MO-M40097C | 0.1 mg |
| mAb anti-Human α-Synuclein, 8F12 | MO-M40097D | 0.1 mg |
| mAb anti-Human α-Synuclein, 9A9 | MO-M40097E | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, 3E11 | MO-M40098A | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B2B3 | MO-M40098B | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B4H12 | MO-M40098C | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B5B11 | MO-M40098D | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B7B10 | MO-M40098E | 0.1 mg |
| mAb anti-Human α1-antichymotrypsin, B7H2 | MO-M40098F | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 1A4 | MO-M40099A | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 7G9 | MO-M40099B | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 9B4 | MO-M40099C | 0.1 mg |
| mAb anti-Thr181 Phosphorylated Tau, 2A4 | MO-M40099D | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 8E1 | MO-M40100A | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 1G8 | MO-M40100B | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4C1 | MO-M40100C | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 3B12 | MO-M40100D | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H1 | MO-M40100E | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 4H11 | MO-M40100F | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 5C11 | MO-M40100G | 0.1 mg |
| mAb anti-human Thr212 Thr217 double phosphorylated Tau, 10G9 | MO-M40100H | 0.1 mg |
| mAb anti-LCRMP4, 5H5 | MO-M40101A | / |
| mAb anti-LCRMP4, 2H7 | MO-M40101B | / |
| mAb anti-LCRMP4 , 7E1 | MO-M40101C | / |
| mAb anti-Human Phospho-STAT5b [p-Y699], A4B9 | MO-P40001A | 0.1 mg |
| mAb anti-Human Phospho-STAT5b [p-Y699], A2H6 | MO-P40001B | 0.1 mg |
| mAb anti-Human Phospho-ELK-1 [p-S383], B4A12 | MO-P40002A | 0.1 mg |
| mAb anti-Human Phospho-ELK-1 [p-S383], D7H2 | MO-P40002B | 0.1 mg |
| mAb anti-Human Phospho-CREB [p-S133], A3A4 | MO-P40003A | 0.1 mg |
| mAb anti-Human Phospho-CREB [p-S133], B1C4 | MO-P40003B | 0.1 mg |
| mAb anti-Human FPRL-1 C-terminal, C4F9 | MO-P40006A | 0.1 mg |
| mAb anti-Human FPRL-1 C-terminal, B4D9B10 | MO-P40006B | 0.1 mg |
| mAb anti-Human FPRL-1 2nd extracellular loop, 3D7 | MO-P40007A | 0.1 mg |
| mAb anti-Human FPRL-1 2nd extracellular loop, B7H10 | MO-P40007B | 0.1 mg |
| mAb anti-Human Lung Carcinoma, CHALU2 | MO-T40005B | 0.1 mg |
| mAb anti-Human Lung Carcinoma, 3504 | MO-T40005C | 0.1 mg |
| mAb anti-Human Hepatocellular Carcinoma, CHALV1 | MO-T40006A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y2, Detector | MO-T40007A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y1, Capture | MO-T40007B | 0.1 mg |
| mAb anti-Human BPH, YBPH-1 | MO-T40008A | 0.1 mg |
| mAb anti-Human BPH, YBPH-2 | MO-T40008B | 0.1 mg |
| mAb anti-Human PML, B3E9 | MO-T40010A | 0.1 mg |
| mAb anti-Human PML, B4C8 | MO-T40010B | 0.1 mg |
| mAb anti-CA 125, 110 | MO-T40012A | 0.1 mg |
| mAb anti-CA 125, 76 | MO-T40012B | 0.1 mg |
| mAb anti-CA 125, 23 | MO-T40012C | 0.1 mg |
| mAb anti-CA 125, 15 | MO-T40012D | 0.1 mg |
| mAb anti-CA 125 | MO-T40012E | 0.1 mg |
| mAb anti-CA50, 93 | MO-T40014A | 0.1 mg |
| mAb anti-CA50, 826 | MO-T40014B | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,8E2 (Free Sample Available) | MO-T40015A | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9B2 (Free Sample Available) | MO-T40015B | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,1A5 (Free Sample Available) | MO-T40015C | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,4E11 (Free Sample Available) | MO-T40015D | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,9E1 (Free Sample Available) | MO-T40015E | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7C4 (Free Sample Available) | MO-T40015F | 0.1 mg |
| mAb anti- human carbohydrate antigen 19-9 (CA 19-9) ,7E6 (Free Sample Available) | MO-T40015G | 0.1 mg |
| mAb anti-Human Colorectal Carcinoma, Y94 | MO-T40022 | 0.1 mg |
| mAb anti-Human Colorectal Carcinoma/CD3, BS-1 | MO-T40035 | 0.1 mg |
| mAb anti-Human CEA, CEA-Y2, Detector | MO-T40051A | 0.1 mg |
| mAb anti-Human CEA, CEA-Y1, Capture | MO-T40051B | 0.1 mg |
| mAb anti-Human Free PSA, 103, Detector | MO-T40052A | 0.1 mg |
| mAb anti-Human Free PSA, 108, Capture | MO-T40052B | 0.1 mg |
| mAb anti-Human PSA, CHYH1, Capture | MO-T40081A | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Dectector | MO-T40081B | 0.1 mg |
| mAb anti-Human PMA, YPMA-1 | MO-T40083A | 0.1 mg |
| mAb anti-Human PMA, YPMA-2 | MO-T40083B | 0.1 mg |
| mAb anti-Human PSP, YPSP-1 | MO-T40085A | 0.1 mg |
| mAb anti-Human PSP, YPSP-2 | MO-T40085B | 0.1 mg |
| mAb anti-Human PSP, YPSP-3 | MO-T40085C | 0.1 mg |
| mAb anti-Human PSP, YPSP-4 | MO-T40085D | 0.1 mg |
| mAb anti-Human PSMA, YPSMA-1 | MO-T40086A | 0.1 mg |
| mAb anti-Human PSMA, YPSMA-2 | MO-T40086B | 0.1 mg |
| mAb anti-Human PSMA, 4H11 | MO-T40086C | 0.1 mg |
| mAb anti-Human PSMA, 7F3 | MO-T40086D | 0.1 mg |
| mAb anti-Human PTMA, 8H12 | MO-T40087A | 0.1 mg |
| mAb anti-Human PTMA, 9A10 | MO-T40087B | 0.1 mg |
| mAb anti-Human PTMA, 6A3 | MO-T40087C | 0.1 mg |
| mAb anti-Human PTMA, 4G2 | MO-T40087D | 0.1 mg |
| mAb anti-Human PTMA, 5A10 | MO-T40087E | 0.1 mg |
| mAb anti-Human PTMA, 6H7 | MO-T40087F | 0.1 mg |
| mAb anti-Human PTMA, 1F2, Capture | MO-T40087G | 0.1 mg |
| mAb anti-Human PTMA, 4C3 | MO-T40087H | 0.1 mg |
| mAb anti-Human PTMA, 4A7, Detector | MO-T40087I | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9A4 | MO-T40088A | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2E6 | MO-T40088B | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 1A10 | MO-T40088C | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 5C2 | MO-T40088D | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 10H9 | MO-T40088E | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2A3 | MO-T40088F | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 2E5 | MO-T40088G | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 5H12 | MO-T40088H | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9C7 | MO-T40088I | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 9D5 | MO-T40088J | 0.1 mg |
| mAb anti-Human S100A7 (psoriasin), 3E7 | MO-T40088K | 0.1 mg |
| Human PSA ELISA Kit | EL10005 | 96 wells |
| Human IL-8 ELISA Kit | EL10008 | 96 wells |
| Human MCAF / MCP-1 ELISA Kit | EL10009 | 96 wells |
| Human EGF ELISA Kit | EL10010 | 96 wells |
| Human LH ELISA Kit | EL10011 | 96 wells |
| Human TSH ELISA Kit | EL10012 | 96 wells |
| Neonatal TSH ELISA Kit | EL10012N | 96 wells |
| Ultra-Sensitive Human TSH ELISA Kit | EL10012U | 96 wells |
| Human FSH ELISA Kit | EL10013 | 96 wells |
| Human Prolactin ELISA Kit | EL10014 | 96 wells |
| Human SAA ELISA Kit | EL10015 | 96 wells |
| Human SAA ELISA Kit (2nd Generation) | EL10015L | 96 wells |
| Human MCP-3 ELISA Kit | EL10016 | 96 wells |
| Human TNF-α ELISA Kit | EL10019 | 96 wells |
| Human GM-CSF ELISA Kit | EL10020 | 96 wells |
| Human IL-16 ELISA Kit | EL10021 | 96 wells |
| High Sensitivity Human CRP ELISA Kit | EL10022hs | 96 wells |
| Human IL-6 ELISA Kit | EL10023 | 96 wells |
| Human IFN-γ ELISA Kit | EL10024 | 96 wells |
| Human IL-2 ELISA Kit | EL10025 | 96 wells |
| Human IL-4 ELISA Kit | EL10026 | 96 wells |
| Human IL-10 ELISA Kit | EL10027 | 96 wells |
| Human IL-1β ELISA Kit | EL10028 | 96 wells |
| Human TGF-β1 ELISA Kit | EL10029 | 96 wells |
| Human Growth Hormone (hGH) ELISA Kit/Hormone Elisa | EL10030 | 96 wells |
| High Sensitivity Human Growth Hormone (H-hGH) ELISA Kit | EL10030H | 96 wells |
| Human Chorionic Gonadotropin (hCG) ELISA Kit | EL10031 | 96 wells |
| Human IL-12 (P70) ELISA Kit | EL10032 | 96 wells |
| Human IL-2 sRα ELISA Kit | EL10033 | 96 wells |
| Human IL-6 sR ELISA Kit | EL10034 | 96 wells |
| Human IL-5 ELISA Kit | EL10035 | 96 wells |
| HAMA ELISA Kit | EL10036 | 96 wells |
| Human IL-13 Rα2 ELISA Kit | EL10039 | 96 wells |
| Human IL-1α ELISA Kit | EL10040 | 96 wells |
| Human IL-7 ELISA Kit | EL10041 | 96 wells |
| Human IL-11 ELISA Kit | EL10042 | 96 wells |
| Human IL-15 ELISA Kit | EL10044 | 96 wells |
| Human M-CSF ELISA Kit | EL10046 | 96 wells |
| Human TNF-β ELISA Kit | EL10047 | 96 wells |
| Human bFGF ELISA Kit | EL10048 | 96 wells |
| Human Alphafetoprotein (AFP) ELISA Kit | EL10049 | 96 wells |
| Human B2MG ELISA Kit | EL10051 | 96 wells |
| Human Carcinoembryonic Antigen (CEA) ELISA Kit | EL10052 | 96 wells |
| Human IL-17A ELISA Kit | EL10053 | 96 wells |
| Human IL-13 ELISA Kit | EL10054 | 96 wells |
| Human IL-22 ELISA Kit | EL10055 | 96 wells |
| Human IL-9 ELISA Kit | EL10056 | 96 wells |
| Human Amyloid Beta Peptide 42 ELISA Kit | EL10057 | 96 wells |
| Human Programmed Death-Ligand 1 (PD-L1) ELISA Kit | EL10058 | 96 wells |
| Human Programmed Death-1 (PD-1) ELISA Kit | EL10059 | 96 wells |
| Human IL-18 ELISA Kit | EL10060 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (Inflammatory) | EM10001 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (M1/M2/MDSC Cytokines) | EM10002 | 96 wells |
| Multiplex Human Cytokine ELISA Kit (Th1/Th2/Th17) | EM10003 | 96 wells |
| Mouse IL-17A ELISA Kit | MEC1001 | 96 wells |
| Mouse IFN-γ ELISA Kit | MEC1002 | 96 wells |
| Mouse TNF-α ELISA Kit | MEC1003 | 96 wells |
| Mouse GM-CSF ELISA Kit | MEC1004 | 96 wells |
| Mouse MCP-1 ELISA Kit | MEC1005 | 96 wells |
| Mouse IL-2 ELISA Kit | MEC1006 | 96 wells |
| Mouse IL-5 ELISA Kit | MEC1007 | 96 wells |
| Mouse IL-6 ELISA Kit | MEC1008 | 96 wells |
| Mouse IL-4 ELISA Kit | MEC1009 | 96 wells |
| Mouse IL-1β ELISA Kit | MEC1010 | 96 wells |
| Mouse IL-1α ELISA Kit | MEC1011 | 96 wells |
| Mouse TGF-β1 ELISA Kit | MEC1012 | 96 wells |
| pAb anti-Human CRP, Tracer (HRP Labeled) | AI20009P | 0.2 mL |
| mAb anti-Human TNF-α, CH8820, Capture | MO-C40003B | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Detector | MO-C40003E | 0.1 mg |
| mAb anti-Human TNF-α, B1E4, Tracer (HRP Labeled) | MO-C40003T | 0.2 mL |
| mAb anti-Human TNF-α, B1E4, Tracer (Biotin Labeled) | MO-C40003TB | 0.1 mL |
| mAb anti-Human IL-8, I8-S2, Capture | MO-C40017A | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Detector | MO-C40017D | 0.1 mg |
| mAb anti-Human IL-8, I8-60, Tracer (HRP Labeled) | MO-C40017T | 0.2 mL |
| mAb anti-Human IL-8, I8-60, Tracer (Biotin Labeled) | MO-C40017TB | 0.1 mL |
| mAb anti-Human MCP-1, S14, Capture | MO-C40021B | 0.1 mg |
| mAb anti-Human MCP-1, S101, Detector | MO-C40021D | 0.1 mg |
| mAb anti-Human MCP-1, S101, Tracer (HRP Labeled) | MO-C40021T | 0.2 mL |
| mAb anti-Human MCP-1, S101, Tracer (Biotin Labeled) | MO-C40021TB | 0.1 mL |
| mAb anti-Human SAA, 115, Capture | MO-C40028A | 0.1 mg |
| mAb anti-Human SAA, 607, Detector | MO-C40028E | 0.1 mg |
| mAb anti-Human SAA, 607, Tracer (HRP Labeled), 0.2mL | MO-C40028T | 0.2 mL |
| mAb anti-Human SAA, 607, Tracer (Biotin Labeled), 0.1mL | MO-C40028TB | 0.1 mL |
| mAb anti-Human EGF, S-134, Capture | MO-C40044D | 0.1 mg |
| mAb anti-Human EGF, S-146, Detector | MO-C40044F | 0.1 mg |
| mAb anti-Human EGF, S-146, Tracer (HRP Labeled) | MO-C40044T | 0.2 mL |
| mAb anti-Human EGF, S-146, Tracer (Biotin Labeled) | MO-C40044TB | 0.1 mL |
| mAb anti-Human MCP-3, 113, Detector | MO-C40088A | 0.1 mg |
| mAb anti-Human MCP-3, 542, Capture | MO-C40088G | 0.1 mg |
| mAb anti-Human MCP-3, 113, Tracer (HRP Labeled) | MO-C40088T | 0.2 mL |
| mAb anti-Human MCP-3, 113, Tracer (Biotin Labeled) | MO-C40088TB | 0.1 mL |
| mAb anti-Human IL-16, 323, Detector | MO-C40089J | 0.1 mg |
| mAb anti-Human IL-16, 398, Capture | MO-C40089K | 0.1 mg |
| mAb anti-Human IL-16, 323, Tracer (HRP Labeled) | MO-C40089T | 0.2 mL |
| mAb anti-Human GM-CSF, 59, Capture | MO-C40090B | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Detector | MO-C40090D | 0.1 mg |
| mAb anti-Human GM-CSF, 429, Tracer (HRP Labeled) | MO-C40090T | 0.2 mL |
| mAb anti-Human GM-CSF, 429, Tracer (Biotin Labeled) | MO-C40090TB | 0.1 mL |
| mAb anti Human IL-18 clone 2A10, Capture | MO-C40094A | 0.1mg |
| mAb anti Human IL-18 clone 10H4, Detector | MO-C40094B | 0.1mg |
| mAb anti human IL-18 clone 10H4, Tracer (Biotin Labeled) | MO-C40094TB | 0.1 mL |
| mAb anti Human IL-15 clone 5E8, Capture | MO-C40095A | 0.1mg |
| mAb anti Human IL-15 clone B1H6, Detector | MO-C40095B | 0.1mg |
| mAb anti human IL-15 clone B1H6, Tracer (Biotin labeled) | MO-C40095TB | 0.1 mL |
| mAb anti-HIV-1 P24 (Core Protein), 473, Detector | MO-I40002A | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 340, Capture | MO-I40002D2 | 0.1 mg |
| mAb anti-HIV-1 P24 (Core Protein), 473, Tracer (HRP), 0.2 mL | MO-I40002T2 | 0.2 mL |
| mAb anti-Human PD-1 / CD279, 7G12, Tracer (Biotin labeled) | MO-L40043TB | 0.1 mL |
| mAb anti Human PD-L1 clone 12B4, Detector | MO-L40044I | 0.1 mg |
| mAb anti Human PD-L1 clone 15G3, Capture | MO-L40044N | 0.1 mg |
| mAb anti human PD-L1 clone 12B4, Tracer (Biotin Labeled) | MO-L40044TB | 0.1 mL |
| mAb anti-hGH, YC6, Capture | MO-M40012A | 0.1 mg |
| mAb anti-hGH, YC8, Tracer (HRP Labeled), 0.2 mL | MO-M40012T | 0.2 mL |
| mAb anti-hGH, YC8, Tracer (Biotin Labeled), 0.1 mL | MO-M40012TB | 0.1 mL |
| mAb anti-Human B2MG, D2E9, Capture | MO-M40021C | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Detector | MO-M40021F | 0.1 mg |
| mAb anti-Human B2MG, D3A2, Tracer (HRP Labeled), 0.2mL | MO-M40021T | 0.2 mL |
| mAb anti-human CRP, 63F4, Capture | MO-M40023A | 0.1 mg |
| mAb anti-human TSH, TSH-2, Detector | MO-M40046A | 0.1 mg |
| mAb anti-human TSH, TSH-1, Capture | MO-M40046B | 0.1 mg |
| mAb anti-human TSH, TSH-2, Tracer (HRP Labeled), 0.2 mL | MO-M40046T | 0.2 mL |
| mAb anti-Human Prolactin, PRL-1, Capture | MO-M40047B | 0.5 mg |
| mAb anti-Human Prolactin, PRL-2, Tracer (HRP Labeled), 0.2 mL | MO-M40047T | 0.2 mL |
| mAb anti-Human LH, LH-1, Capture | MO-M40048B | 0.5 mg |
| mAb anti-Human LH, LH-2, Tracer (HRP Labeled), 0.2 mL | MO-M40048T | 0.2 mL |
| mAb anti-hCG, HCG-1, Capture | MO-M40049B | 0.5 mg |
| mAb anti-hCG, HCG-2, Tracer (HRP Labeled), 0.2 mL | MO-M40049T | 0.2 mL |
| mAb anti-Human FSH, FSH-1, Capture | MO-M40050B | 0.5 mg |
| mAb anti-Human FSH, FSH-2, Tracer (HRP Labeled) | MO-M40050T | 0.2 mL |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Detector | MO-M40093B | 0.5 mg |
| mAb anti-Amyloid β Peptide 42, CA9 10C11, Tracer (Biotin) | MO-M40093TB | 0.1 mL |
| mAb anti-Amyloid β Peptide N-terminal, NT 5B8, Capture | MO-M40094D | 0.5 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Detector | MO-M40095A | 0.1 mg |
| mAb anti-Amyloid β Peptide 40, CV9 7B10, Tracer (Biotin) | MO-M40095TB | 0.1 mL |
| mAb anti-Human AFP, AFP-Y2, Detector | MO-T40007A | 0.1 mg |
| mAb anti-Human AFP, AFP-Y1, Capture | MO-T40007B | 0.1 mg |
| mAb anti-Human AFP, AFP-2, Tracer (HRP Labeled), 0.2 mL | MO-T40007T | 0.2 mL |
| mAb anti-Human CEA, CEA-Y2, Detector | MO-T40051A | 0.1 mg |
| mAb anti-Human CEA, CEA-Y1, Capture | MO-T40051B | 0.1 mg |
| mAb anti-Human CEA, CEA-Y2, Tracer (HRP Labeled), 0.2 mL | MO-T40051T | 0.2 mL |
| mAb anti-Human Free PSA, 103, Detector | MO-T40052A | 0.1 mg |
| mAb anti-Human Free PSA, 108, Capture | MO-T40052B | 0.1 mg |
| mAb anti-Human Free PSA, 103, Tracer (HRP Labeled), 0.2 mL | MO-T40052T | 0.2 mL |
| mAb anti-Human PSA, CHYH1, Capture | MO-T40081A | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Dectector | MO-T40081B | 0.1 mg |
| mAb anti-Human PSA, CHYH2, Tracer (HRP Labeled), 0.2 mL | MO-T40081T | 0.2 mL |
| Human Chorionic Gonadotrophin (hCG), 10 mg | AP30002 | 10 mg |
| Human Immunoglobulin G (IgG), 10 mg | IG30001 | 10 mg |
| Mouse Immunoglobulin G (IgG), 10 mg | IG41002 | 10 mg |
| Mouse Immunoglobulin G2b (IgG2b), 10 mg | IG41004 | 10 mg |
| Rat Immunoglobulin G (IgG) | IG42003 | 10 mg |
| Human Umbilical Cord Serum, 10 mL | S30010 | 10 mL |
| ELISA Coating (EC) Stabilizer, 500 mL | S7001 | 500 mL |
| Human IL-8 Matched Antibody Pair for ELISpot | SL10008A | 5 × 96 wells |
| Human IL-8 Development Set for ELISpot | SL10008B | 5 × 96 wells |
| Human IL-8 ELISpot Kit | SL10008E | 6 X 96 wells |
| Human MCAF (MCP-1) Matched Antibody Pair for ELISpot | SL10009A | 5 × 96 wells |
| Human MCAF (MCP-1) Development Set for ELISpot | SL10009B | 5 × 96 wells |
| Human MCAF (MCP-1) ELISpot Kit | SL10009E | 6 X 96 wells |
| Human GM-CSF Matched Antibody Pair for ELISpot | SL10020A | 5 × 96 wells |
| Human GM-CSF Development Set for ELISpot | SL10020B | 5 × 96 wells |
| Human GM-CSF ELISpot Kit | SL10020E | 6 X 96 wells |
| Human IFN-γ Matched Antibody Pair for ELISpot | SL10024A | 5 × 96 wells |
| Human IFN-γ Development Set for ELISpot | SL10024B | 5 × 96 wells |
| Human IFN-γ ELISpot Kit | SL10024E | 6 X 96 wells |
| Human IL-12 (P70) ELISpot Kit | SL10032E | 6 X 96 wells |
| TMB Solution (500 mL Part A & 500 mL Part B) | SU6006 | 1.0 L |
| pAb Rabbit anti-HCV Virus, 1.0 mg | AI20006P | 1.0 mg |
| pAb Rabbit anti-HIV-1 p24, 1.0 mg | AI20008P | 1.0 mg |
| pAb anti-Human CRP, Tracer (HRP Labeled) | AI20009P | 0.2 mL |
| pAb Rabbit anti-Mouse IgG , 1.0 mg | AI50005 | 1.0 mg |
| pAb Rabbit anti-Mouse IgG - HRP Conjugated, 1.0 mL | AI50005P | 1.0 mL |
| pAb Rabbit anti-hGH, | AI50006P | 1.0 mg |
| pAb Chicken anti-human IL-8 (IgY fraction) | AI60001 | 1.0 mg |
| pAb Rabbit anti-Human FPRL-1 2nd Extracellular Loop | AI70001A | 0.1 mg |
| pAb Rabbit anti-Human FPRL-1 C-terminal | AI70001B | 0.1 mg |
| pAb Rabbit anti-Human PML [Ring Finger Domain] | AI70002A | 0.1 mg |
| pAb Rabbit anti-Human PML [B-box 1 domain] | AI70002B | 0.1 mg |
| pAb Rabbit anti-Bcl-2 | AI70003A | 0.1 mg |
| pAb Rabbit anti-Phospho-Bcl-2 (Thr56) | AI70003B | 0.1 mg |
| pAb Rabbit anti-Phospho-Bcl-xL (Thr115) | AI70003D | 0.1 mg |
| pAb Rabbit anti-Phospho c-kit (Tyr719) | AI70004A | 0.1 mg |
| pAb Rabbit anti-Phospho IKK-γ (Ser31) | AI70005A | 0.1 mg |
| pAb Rabbit anti-NF-κB-p65 (RelA) | AI70006A | 0.1 mg |
| pAb Rabbit anti-Phospho-NF-қB-p65 (Ser276) | AI70007A | 0.1 mg |
| pAb Rabbit anti-Phospho-NF-қB-p65 (Ser468) | AI70008A | 0.1 mg |
| pAb Rabbit anti-Phospho NF-қB-p105/p50 (Ser337) | AI70009A | 0.1 mg |
| pAb Rabbit anti-Human Serum Albumin (HSA) | AI80001 | 0.1 mg |
| pAb Rabbit anti-Human Fibrinogen, 0.1 mg | AI80002 | 0.1 mg |
| pAb Rabbit anti-Human Transferrin | AI80003 | 0.1 mg |
| pAb Rabbit anti-Human IgA, 0.5 mg | AI80004 | 0.5 mg |
| pAb Rabbit anti-human IgM, 0.5 mg | AI80005 | 0.5 mg |
| pAb Rabbit anti-Human TREK-1 (K2p2.1) | AI80006A | 0.1 mg |
| pAb Rabbit anti-Mouse Kchip1 | AI80007 | 0.1 mg |
| pAb Rabbit anti-Mouse Kchip4 | AI80008 | 0.1 mg |
| pAb Rabbit anti-Mouse Kv4.3 | AI80010A | 0.1 mg |
| pAb Rabbit anti-Mouse TRPV1 | AI80011A | 0.1 mg |
| pAb Rabbit anti-Mouse TRPV3 | AI80012A | 0.1 mg |
| pAb Rabbit anti-Human JAK2 | AI80013A | 0.1 mg |
| pAb Rabbit anti-Human Glutathione S Transferase (GST), 0.1 mg | AI80014 | 0.1 mg |
| pAb Rabbit anti-Human Amyloid beta peptide 42 | AI90001 | 0.1 mg |
| pAb Rabbit anti-Human Amyloid beta peptide 43 | AI90002 | 0.1 mg |

艾美捷科技代理Rel Assay Diagnostics品牌全系列产品
Rel Assay Diagnostics(MEGA TIP 集团旗下公司)是一家总部位于加济安泰普(土耳其)的公司,成立于1993年。该公司提供用于氧化应激检测的诊断试剂盒。例如:对氧磷酶检测试剂盒、芳基酯酶检测试剂盒、PON1 192Q/R 表型分型试剂盒、第三代总抗氧化状态 (TAS) 检测试剂盒、总氧化状态 (TOS) 检测试剂盒、氧化应激指数检测试剂盒以及总硫醇检测试剂盒,这些试剂盒可用于检测血清、血浆、细胞裂解液和组织匀浆等样本。

▍Rel Assay Diagnostics产品列表
| 品名 | Volumes | 货号 |
| Total Antioxidant Status Assay Kit | R1:30ml R2:8ml Std:4ml QC L1: 4ml QC L2: 4ml | RL0017 |
| Total Oxidant Status Assay Kit | R1:30ml R2:8ml Std:4ml QC L1: 4ml QC L2: 4ml | RL0024 |
| Paraoxonase assay Kit | R1:30ml R2:6ml | RL0031 |
| Arylesterase Assay Kit | Buffered Diluent:30ml R2:8ml R3:15ml | RL0055 |
| Total Thiol Assay Kit | R1A:0.2ml R1B:15ml R2:30ml R3:6ml | RL0178 |
| Native Thiol Assay Kit | R1:30ml R2:6ml | RL0185 |
| Zinc assay Kit | R1:50ml R2:10ml Std:4ml QC L1: 4ml QC L2: 4ml | RL1116 |
| Zinc assay Kit | 2xR1:50ml 2xR2:10ml Std:4ml QC L1: 4ml QC L2: 4ml | RL2116 |
| Zinc assay Kit | 3xR1:50ml 3xR2:10ml Std:4ml QC L1: 4ml QC L2: 4ml | RL3116 |
| Copper assay Kit | R1:50ml R2:10ml Std:4ml QC L1: 4ml QC L2: 4ml | RL0123 |
| Nadp-IDH Isocitrate Dehydrogenase Assay Kit | R1:30ml QC L1: 3ml QC L2: 3ml | RL0315 |
| Phosphorus (Inorganic) | R1:30ml R2:30ml Std:4ml QC L1: 4ml QC L2: 4ml | RL0247 |
| Glutamate Dehydrogenase | R1:30ml QC L1: 3ml QC L2: 3ml | RL0401 |
| Malate Dehydrogenase | R1:30ml R2:6ml | RL0405 |
| G6PD Glucose 6 Phpsphate Dehydrogenase | R1:30ml R2:8ml QC L1: 4ml QC L2: 4ml | RL0745 |
| G6PD Glucose 6 Phpsphate Dehydrogenase | R1:30 ml R2:8 ml | RL0745 |
| G6PD Glucose 6 Phpsphate Dehydrogenase | QC L1:1ml, QC L2:1ml | RL0745 |

LC Laboratories(LC Labs)公司成立于1980年,一直专注于信号转导,肿瘤以及其他临床前试剂的研究和生产,主要提供抗癌物质、酶抑制剂、激活剂和离子通道试剂。LC Labs公司不但拥有大规模的制备液相色谱纯化能力,也开发和优化了大量的具有自主知识产权的低成本高纯度生成方法,其生产的小分子试剂纯度高、价格低和销量大。
1980年,LC Labs是PMA(佛波醇12-豆蔻酸 13醋酸;TPA)的全球主要生产商,36年来的销售量超过150,000瓶;1989年为研究试剂市场提供第一个纯度高价格低的毒萝卜素;1990年提供第一个纯度高价格低的冈田酸;1991年提供第一个纯度高价格低的花萼海绵诱癌素A,并且持续是这种广泛使用的磷酸酶抑制剂的全球主要生产商;1995年提供第一个异构体级别纯度的低价格Gö 6976;1996年提供第一个纯度高价格低的罗霉素A1;2002年提供第一个纯度高价格低的雷帕霉素(抗真菌抗生素);同年,提供第一个纯度高、价格低的FK-506;2003年提供第一个纯度高价格低的来普霉素B;2004年提供第一个纯度高价格低的星孢菌素;同年,提供第一个纯度高价格低的环巴胺;2007年,LC Labs公司为临床前肿瘤相关研究引入第一组纯度高价格低的常用蛋白激酶抑制剂。
热销产品:
Bortezomib硼替佐米(99%,97%)
Cyclosporine-A环胞霉素A
Cyclopamine环巴胺
17-DMAG,Hydrochloride SaltHSP90抑制剂
Everolimus依维莫司
FK-506他克莫司
Forskolin腺苷酸环化酶激活剂
Gefitinib吉非替尼
Leptomycin B细霉素B 出核转运抑制剂
LY 294002PI3-K抑制剂
PD98059MEK抑制剂
RoscovitineCDK抑制剂
Rapamycin雷帕霉素
SB 202190MAPK抑制剂
SB203580P38MAPK抑制剂
SP600125JNK抑制剂
Staurosporine星孢菌素
UO126MAPK抑制剂
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://anogen.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="LC Laboratories"> LC Laboratories地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:15172431432
传真:18771997407
邮箱:sales@amyjet.com
0.3445